# K140266: Nmi Picc IV

- Pathway: 510(k) (Special)
- Applicant: Navilyst Medical, Inc.
- Decided: Mar 5, 2014 after 30 days
- Product code: LJS (Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5970
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 13 generations back to K001901 (2000). 46 ancestors in all.
3 later devices descend from it; 3 cite it directly.
2 of 50 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K133264: Nmi Picc Iii, Navilyst Medical, Inc. (2013) Summary page 1.
- K131942: Nmi Picc Iii Catheter, Nmi Hpicc Iii Catheter, Navilyst Medical, Inc. (2013) Summary page 1.

## Most influential descendants
- K153469: Cathtong I PICC Catheter (2016), 0 descendants of its own
- K150109: Arrow Pressure Injectable Jugular Axillo-subclavian Central Catheter (JACC) with Sustain Technology (2015), 0 descendants of its own
- K150448: NMI PICC III and NMI PICC IV (2015), 0 descendants of its own

## Indications for use
The NMI P1CC IV is indicated for short- or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients, the sampling of blood, for central venous pressure monitoring and for power injection of contrast media. Maximum Power Injection Flow Rate 3F Single Lumen - 55cm length 1 ml/sec 4F Single Lumen - 55cm length 3.5 ml/sec 5F Single Lumen - 55cm length 5 mL/sec 5F Dual Lumen - 55 cm length 4 ml/sec 6F Dual Lumen - 55cm length 5 mL/sec 6F Triple Lumen - 55cm length 6 mL/sec

Source page: https://510kreport.com/device/K140266
Methodology: https://510kreport.com/methodology